PI3 kinase
| 6 min read
Judy Sebolt-Leopold and her team at MEKanistic Therapeutics developed a single molecule targeting two kinase enzymes that drive resistance to cancer therapies.
| 7 min read
A search for a new cancer mouse model turned into the first ever treatment for a rare disease called venous malformations.
Page 1 of 1 - 2 Total Items
